IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PIZZI, Marina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.941
EU - Europa 7.285
AS - Asia 5.328
SA - Sud America 946
AF - Africa 94
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 17
AN - Antartide 1
Totale 23.630
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.788
PL - Polonia 3.255
CN - Cina 1.846
SG - Singapore 1.633
UA - Ucraina 1.048
BR - Brasile 804
DE - Germania 750
IT - Italia 718
HK - Hong Kong 600
VN - Vietnam 391
GB - Regno Unito 345
FI - Finlandia 324
IN - India 295
RU - Federazione Russa 237
TR - Turchia 201
IE - Irlanda 178
FR - Francia 174
CA - Canada 79
BD - Bangladesh 72
ID - Indonesia 64
MX - Messico 49
AR - Argentina 48
NL - Olanda 47
SE - Svezia 43
BE - Belgio 41
JP - Giappone 38
ZA - Sudafrica 35
KR - Corea 33
CZ - Repubblica Ceca 31
IQ - Iraq 27
AT - Austria 25
ES - Italia 25
EC - Ecuador 23
CO - Colombia 21
PK - Pakistan 19
IR - Iran 17
UZ - Uzbekistan 17
EU - Europa 16
AU - Australia 15
IL - Israele 15
MA - Marocco 15
KE - Kenya 14
CL - Cile 11
PY - Paraguay 11
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
SA - Arabia Saudita 9
AZ - Azerbaigian 8
LT - Lituania 8
PE - Perù 8
UY - Uruguay 7
ET - Etiopia 6
JM - Giamaica 6
JO - Giordania 6
MU - Mauritius 6
TN - Tunisia 6
CH - Svizzera 5
EG - Egitto 5
LV - Lettonia 5
OM - Oman 5
HN - Honduras 4
KZ - Kazakistan 4
RO - Romania 4
BG - Bulgaria 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
EE - Estonia 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
AL - Albania 2
AM - Armenia 2
CR - Costa Rica 2
DK - Danimarca 2
DZ - Algeria 2
GE - Georgia 2
GR - Grecia 2
MD - Moldavia 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
GA - Gabon 1
GD - Grenada 1
GS - Georgia del Sud e Isole Sandwich Australi 1
GT - Guatemala 1
HR - Croazia 1
KY - Cayman, isole 1
LB - Libano 1
LY - Libia 1
MK - Macedonia 1
NI - Nicaragua 1
NO - Norvegia 1
Totale 23.620
Salva come PNG Salva come JPEG
Città #
Warsaw 3.250
Fairfield 1.040
Woodbridge 812
Ashburn 807
Jacksonville 732
Singapore 706
Houston 617
Hong Kong 594
Ann Arbor 491
Chandler 474
Cambridge 441
Beijing 415
Seattle 406
Wilmington 386
Princeton 315
Nanjing 298
Brescia 281
New York 244
Los Angeles 213
Dearborn 206
Dublin 177
Dallas 166
Helsinki 164
Istanbul 162
Dong Ket 126
Munich 111
Des Moines 100
Buffalo 98
The Dalles 91
Nanchang 90
Chicago 85
Pune 83
Ho Chi Minh City 81
Shenyang 79
San Francisco 76
Milan 74
Moscow 73
São Paulo 72
Hebei 71
Jinan 69
Redondo Beach 68
Tianjin 68
Lancaster 65
Shanghai 65
Changsha 60
Hanoi 56
San Diego 52
Jakarta 48
London 47
Santa Clara 41
Brussels 38
Phoenix 37
Turku 35
Kunming 32
Denver 30
Jiaxing 30
Toronto 30
Brooklyn 28
Guangzhou 28
Ningbo 28
Zhengzhou 28
Salt Lake City 27
Hangzhou 25
Nuremberg 24
Rio de Janeiro 23
Chennai 22
Lanzhou 22
Taizhou 22
Tokyo 22
Verona 21
Montreal 20
Norwalk 20
Boardman 19
Brasília 19
Brno 19
Orem 19
Amsterdam 18
Boston 18
Orange 18
Tampa 18
Belo Horizonte 17
Haikou 17
Johannesburg 17
Mexico City 17
Porto Alegre 17
Rome 17
Stockholm 17
Tashkent 17
Atlanta 16
San Mateo 16
Augusta 15
Manchester 15
Poplar 15
Romola 14
Thái Bình 14
Vienna 14
Dhaka 13
Elk Grove Village 13
Kocaeli 13
Mumbai 13
Totale 16.393
Salva come PNG Salva come JPEG
Nome #
CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid 355
Neuroprotective and Anti-Apoptotic Effects of CSP-1103 in Primary Cortical Neurons Exposed to Oxygen and Glucose Deprivation 336
PEA and luteolin synergistically reduce mast cell-mediated toxicity and elicit neuroprotection in cell-based models of brain ischemia 310
Glutamatergic neurons induce expression of functional glutamatergic synapses in primary myotubes. 309
Glutamatergic Reinnervation and Assembly of Glutamatergic Synapses in Adult Rat Skeletal Muscle Occurs at Cholinergic Endplates 299
1B/(-)IRE DMT1 Expression during Brain Ischemia Contributes to Cell Death Mediated by NF-κB/RelA Acetylation at Lys310 292
Dopamine transporter/α-synuclein complexes are altered in the post mortem caudate putamen of Parkinson’s disease: An in situ proximity ligation assay study 288
Glutamatergic reinnervation through peripheral nerve graft dictates assembly of glutamatergic synapses at rat skeletal muscle 278
Priming of cultured neurons with sabeluzole results in long-lasting inhibition of neurotoxin-induced tau expression and cell death. 272
NF-κB and epigenetic mechanisms as integrative regulators of brain resilience to anoxic stress. 270
Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window. 268
NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases 266
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease 263
Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model 262
The End Is the Beginning: Parkinson's Disease in the Light of Brain Imaging 255
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice. 253
A Polyphenol-Enriched Supplement Exerts Potent Epigenetic-Protective Activity in a Cell-Based Model of Brain Ischemia 253
Mild inflammatory profile without gliosis in the c-rel deficient mouse modeling a late-onset parkinsonism 252
Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation 251
The Contribution of -Synuclein Spreading to Parkinson’s Disease Synaptopathy 248
Synergistic association of valproate and resveratrol reduces brain injury in ischemic stroke 243
Pharmacological targeting of the beta-amyloid precursor protein intracellular domain 217
1,2,4-Triazine derivatives as agents for the prevention of AGE-RAGE-mediated inflammatory cascade in THP-1 monocytes: An approach to prevent inflammation-induced late diabetic complications 214
Mitochondria and alpha-synuclein: Friends or foes in the pathogenesis of Parkinson's disease? 200
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 192
Chapter 24 NF-KappaB Dimers in the Regulation of Neuronal Survival 187
Targeting IKK2 by pharmacological inhibitor AS602868 prevents excitotoxic injury to neurons and oligodendrocytes. 184
The gamma-Secretase Modulator CHF5074 Reduces the Accumulation of Native Hyperphosphorylated Tau in a Transgenic Mouse Model of Alzheimer's Disease 184
NUOVO IMPIEGO TERAPEUTICO PREVENTIVO DELLA SUBUNITA' C-REL DELLA PROTEINA NF-KAPPAB E NUOVO IMPIEGO DI UN ANIMALE TRASGENICO NON UMANO CHE PORTA LA DELEZIONE DEL GENE C-REL (C-REL-/-) 184
The Role of Mast Cells in Stroke 184
NF-κB/c-Rel deficiency causes Parkinson's disease-like prodromal symptoms and progressive pathology in mice 183
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate 183
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 181
c-Rel deficient mice, a mouse model of "spreading" PD-like pathology. 180
Spinal cord mGlu1a receptors - Possible target for amyotrophic lateral sclerosis therapy 179
Post-ischemic brain damage: NF-kappaB dimer heterogeneity as a molecular determinant of neuron vulnerability 173
NF-kappaB p50/RelA and c-Rel-containing dimers: opposite regulators of neuron vulnerability to ischaemia. 172
Bim and Noxa are candidates to mediate the deleterious effect of the NF-kappa B subunit RelA in cerebral ischemia. 169
Activation of dopamine D2 receptors linked to voltage-sensitive potassium channels reduces forskolin-induced cyclic AMP formation in rat pituitary cells. 169
A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release. 169
A Tau antisense oligonucleotide decreases neurone sensitivity to excitotoxic injury. 166
Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line 160
α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons 158
Activation of multiple metabotropic glutamate receptor subtypes prevents NMDA-induced excitotoxicity in rat hippocampal slices. 158
EXACERBATED AGE-DEPENDENT LOSS OF NIGRAL DOPAMINERGIC NEURONS IN NF-KAPPAB C-REL -/- MICE 155
Cellular mechanisms for neurotensin receptor-mediated release of prolactin. 151
The gamma-secretase modulator CHF5074 elicits neuroprotection and increases histone acetylation in primary cortical neurons exposed to oxygen glucose deprivation 150
Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells. 150
c-Rel deficient mice, a mouse model of “spreading” PD-like pathology 150
Antisense strategy unravels tau proteins as molecular risk factors for glutamate-induced neurodegeneration. 149
N-methyl-D-aspartate neurotoxicity in hippocampal slices: protection by aniracetam. 148
Synapsin III alterations in Parkinson's disease 147
Electrophysiological and metabolic effects of CHF5074 in the hippocampus: protection against in vitro ischemia. 146
Mitochondrial Dysfunction and Alpha-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First? 145
Cortical neurons induce the expression of glutamate receptors in primary myotubes 143
Degenerazione età –dipendente dei neuroni dopaminergici della sostanza nera nei topi NF-kappaB cRel 143
Synergistic association of valproate and resveratrol reduces brain injury in ischemic stroke. 143
A bioinformatics analysis of memory consolidation reveals involvement of the transcription factor c-rel. 141
SYNERGIC ROLE OF RESVERATROL AND HDACi MS-275 IN NEUROPROTECTION 141
Inhibition of glutamate-induced neurotoxicity by a tau antisense oligonucleotide in primary culture of rat cerebellar granule cells 138
Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells. 136
Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells. 136
Acetylation of NF-kappaB p50/RelA and histones in the epigenetic regulation of pro-apoptotic transcription: a neuroprotective target in brain ischemia 135
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 135
Pharmacological basis for dopamine D-2 receptor diversity 134
Dopamine D2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices. 133
Differential expression of fetal and mature tau isoforms in primary cultures of rat cerebellar granule cells during differentiation in vitro 133
Tolerance to hypoactivity and sensitization to hyperactivity after chronic treatment with a presynaptic dose of lisuride in rats 131
Repeated administration of (−) sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions 131
Inhibition of IκBα phosphorylation prevents glutamate-induced NF-κB activation and neuronal cell death 131
Differential pattern of expression of G proteins in nucleus striatum from 6-hydroxydopamine lesioned rats. 130
Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol. 129
Risk and protective factors associated with mental health status in an Italian sample of students during the fourth wave of COVID-19 pandemic 128
Opposing regulation of amyloid precursor protein by ionotropic and metabotropic glutamate receptors. 128
Lack of vasoactive intestinal peptide-releasing property in prolactin cells from ovariectomized rats: contribution of post-transductional impairments 127
The differential coupling mechanism of dopamine D-2 receptor subtypes: importance for the actions of neuroleptic drugs 126
An in vitro method of diagnosing Parkinson's disease 126
Spinal cord mGlu1a receptors: possible target for amyotrophic lateral sclerosis therapy. 126
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease 126
Various Ca2+ entry blockers prevent glutamate-induced neurotoxicity. 126
Peripheral and central mechanisms of action of serotoninergic anorectic drugs. 122
Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices 121
A soluble interleukin-6 (IL6) recepetor/IL6 fusion protein enhances the in vitro differentiation of purified rat oligodendroglial lineage cells 121
Properties of benzodiazepine binding sites in peripheral blood lymphocytes 120
Post-synaptic D1 and D2 dopamine receptors are present in rabbit renal and mesenteric arteries 119
Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation 119
Synapsin III Alteration in Parkinson's disease 119
Involvement of Synapsin III in the onset of Alpha-synuclein pathology in Parkinson’s Disease 119
Leptin increases axonal growth cone size in developing mouse cortical neurons by convergent signals inactivating glycogen synthase kinase-3beta. 117
NF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production 117
Differential up-regulation of D-1 and D-2 dopamine receptor function in mesostriatal areas but not in cortical-limbic brain regions of rats chronically treated with (?)sulpiride and SCH 23390 117
The inhibitor of IkappaBalpha phosphorylation BAY 11-7082 prevents NMDA neurotoxicity in mouse hippocampal slices. 116
DIVALENT METAL TRANSPORTER 1-DEPENDENT ISCHEMIC NEURODEGENERATION: STRATEGIES TO KNOCKDOWN FERROUS IRON UPTAKE 116
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of Parkinson’s disease and dementia with Lewy bodies, 116
Group-I metabotropic glutamate receptors: hypotheses to explain their dual role in neurotoxicity and neuroprotection. 115
CHF5074, a novel gamma-secretase modulator, attenuates brain beta-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease. 115
The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury. 115
Possible new targets for GPCR modulation: allosteric interactions, plasma membrane domains, intercellular transfer and epigenetic mechanisms 115
AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons of Synapsin III knockout mice reveals novel molecular features involved in Parkinson's disease pathology. 115
Synapsin III Alteration in Parkinson's disease 115
Totale 17.265
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.203
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.203
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.955 0 0 0 0 0 293 190 336 404 267 279 186
2021/20221.396 121 272 25 37 25 64 87 77 70 181 129 308
2022/20231.311 187 34 56 102 134 329 3 132 192 27 58 57
2023/20241.384 92 34 120 82 68 325 55 66 276 31 33 202
2024/20253.480 24 44 34 408 344 208 335 122 513 164 864 420
2025/20264.061 707 896 551 1.048 745 114 0 0 0 0 0 0
Totale 24.203